End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-27 pm EDT
|
5-day change
|
1st Jan Change
|
16.91
CNY
|
-1.57%
|
|
-2.03%
|
-11.47%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
8,159
|
14,737
|
11,674
|
9,611
|
11,206
|
9,913
|
-
|
-
|
Enterprise Value (EV)
1 |
8,159
|
14,737
|
11,674
|
9,611
|
11,206
|
9,913
|
9,913
|
9,913
|
P/E ratio
|
24.6
x
|
119
x
|
28.7
x
|
24.4
x
|
21.7
x
|
16.2
x
|
13.1
x
|
10.7
x
|
Yield
|
-
|
-
|
-
|
0.61%
|
-
|
1.42%
|
1.71%
|
2.07%
|
Capitalization / Revenue
|
9.7
x
|
17.4
x
|
7.3
x
|
6.36
x
|
6.43
x
|
4.93
x
|
4.16
x
|
3.52
x
|
EV / Revenue
|
9.7
x
|
17.4
x
|
7.3
x
|
6.36
x
|
6.43
x
|
4.93
x
|
4.16
x
|
3.52
x
|
EV / EBITDA
|
-
|
79,754,215
x
|
-
|
13,523,933
x
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
4.61
x
|
4.06
x
|
3.12
x
|
3.02
x
|
2.36
x
|
2.05
x
|
1.76
x
|
Nbr of stocks (in thousands)
|
501,788
|
588,997
|
588,984
|
587,124
|
586,727
|
586,193
|
-
|
-
|
Reference price
2 |
16.26
|
25.02
|
19.82
|
16.37
|
19.10
|
16.91
|
16.91
|
16.91
|
Announcement Date
|
2/28/20
|
3/25/21
|
4/26/22
|
4/19/23
|
3/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
840.9
|
848.1
|
1,599
|
1,511
|
1,742
|
2,012
|
2,380
|
2,814
|
EBITDA
|
-
|
184.8
|
-
|
710.7
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
153
|
535.9
|
455.5
|
593.9
|
705.5
|
860.5
|
1,061
|
Operating Margin
|
-
|
18.05%
|
33.5%
|
30.15%
|
34.1%
|
35.06%
|
36.15%
|
37.7%
|
Earnings before Tax (EBT)
1 |
-
|
136.9
|
537
|
449.4
|
593.6
|
706
|
860
|
1,061
|
Net income
1 |
-
|
112.3
|
405.7
|
389.1
|
523.7
|
615.4
|
757
|
933.8
|
Net margin
|
-
|
13.24%
|
25.36%
|
25.76%
|
30.07%
|
30.58%
|
31.8%
|
33.18%
|
EPS
2 |
0.6600
|
0.2100
|
0.6900
|
0.6700
|
0.8800
|
1.045
|
1.290
|
1.585
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
0.1000
|
-
|
0.2400
|
0.2900
|
0.3500
|
Announcement Date
|
2/28/20
|
3/25/21
|
4/26/22
|
4/19/23
|
3/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
4.46%
|
12.1%
|
12.7%
|
14.9%
|
14.5%
|
15.6%
|
16.6%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
8.71%
|
-
|
10.3%
|
10.9%
|
11.5%
|
Assets
1 |
-
|
-
|
-
|
4,466
|
-
|
5,975
|
6,945
|
8,120
|
Book Value Per Share
2 |
-
|
5.430
|
4.880
|
5.250
|
6.330
|
7.180
|
8.250
|
9.590
|
Cash Flow per Share
2 |
-
|
0.2100
|
0.5800
|
0.6700
|
0.9900
|
0.7100
|
1.120
|
1.340
|
Capex
1 |
-
|
16.9
|
65
|
96.5
|
147
|
126
|
136
|
151
|
Capex / Sales
|
-
|
1.99%
|
4.06%
|
6.39%
|
8.44%
|
6.26%
|
5.71%
|
5.37%
|
Announcement Date
|
2/28/20
|
3/25/21
|
4/26/22
|
4/19/23
|
3/29/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -11.47% | 1.39B | | -6.41% | 12.2B | | -4.07% | 8.22B | | +5.77% | 5.72B | | +28.13% | 5.42B | | -59.44% | 2.7B | | +8.04% | 2.63B | | -6.47% | 2.38B | | +21.84% | 2.1B | | -8.15% | 1.81B |
Diagnostic & Testing Substances
|